Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Vassiliki Kotoula"'
Autor:
Angelos Koutras, Georgia Raptou, Dimitrios Pectasides, Ioannis Kostopoulos, Eleftheria Tsolaki, Gerasimos Aravantinos, Zoi Alexopoulou, Dimitrios Bafaloukos, Amanda Psyrri, Helen Gogas, Konstantine T. Kalogeras, George Fountzilas, Ioannis Xanthakis, Pavlos Papakostas, George Pentheroudakis, Elpida Charalambous, Mattheos Bobos, Kalliopi Petraki, Vassiliki Kotoula, Christos Christodoulou
Publikováno v:
Journal of Translational Medicine
Background There is an unmet need for more efficient patient stratification for receiving trastuzumab in the metastatic breast cancer (mBC) setting, since only part of such patients benefit from the addition of this agent to chemotherapy. The aim of
Autor:
Ioannis Xanthakis, Konstantine T. Kalogeras, Nikolaos Xiros, Anna Batistatou, George Pentheroudakis, George Fountzilas, Pavlos Papakostas, Vassiliki Kotoula, Anna Koumarianou, Anastasia G Eleftheraki, Mattheos Bobos, Irene Papaspirou, Christos Christodoulou, Dimosthenis Skarlos, Dimitrios Bafaloukos
Publikováno v:
Journal of Translational Medicine
Journal of Translational Medicine, Vol 10, Iss 1, p 212 (2012)
Journal of Translational Medicine, Vol 10, Iss 1, p 212 (2012)
Background The vast majority of patients with HER2-positive metastatic breast cancer (MBC) treated with trastuzumab eventually develop resistance to this agent. There is an unmet need therefore, for identifying biological markers with possible progno
Autor:
P. Arapantoni, Dimitrios Vlachodimitropoulos, Olympia Tzaida, Mattheos Bobos, Christos Valavanis, Konstantine T. Kalogeras, Christos Christodoulou, Gerasimos Aravantinos, George Pentheroudakis, Anna Batistatou, Anastasia G Eleftheraki, Vassiliki Kotoula, Nikolaos Soupos, Dimitrios Pectasides, Ralph M. Wirtz, Eleni Timotheadou, George Fountzilas, Genovefa Polychronidou, Angelos Koutras, Ralf Kronenwett, Helen Gogas
Publikováno v:
Journal of Translational Medicine
Journal of Translational Medicine, Vol 10, Iss 1, p 10 (2012)
Journal of Translational Medicine, Vol 10, Iss 1, p 10 (2012)
Background HER2 and TOP2A parameters (gene status, mRNA and protein expression) have individually been associated with the outcome of patients treated with anthracyclines. The aim of this study was to comprehensively evaluate the prognostic/predictiv